Roha Khalid, MD $$

Pediatric Neurologist

Associate Professor at UT Southwestern Medical Center

Languages Spoken:


UT Southwestern Pediatric Group

Request an Appointment

Refer a Patient


Roha Khalid, M.D., is an pediatric neurologist (epileptologist) at Children's Health and an associate professor at UT Southwestern Medical Center. She specializes in seizure disorders, including genetic epileptic encephalopathies, medically intractable epilepsy, neonatal seizures, and post-stroke epilepsy.

Dr. Roha Khalid (MD, Neurology) chats with Gracelyn Elzey - Children's Health Plano

Dr. Khalid earned her medical degree at Aga Khan University Medical College and completed her fellowship at the University of Kansas/Children's Mercy Hospital in epilepsy.

She is certified in child neurology and epilepsy by the American Board of Psychiatry and Neurology, Dr. Khalid joined Children's Health in 2022.

She is a member of the American Academy of Neurology, the International Pediatric Stroke Organization, the Newborn Brain Society, and the American Epilepsy Society.

Education and Training

Medical School
Aga Khan University Medical College (2008)
Duke University Medical Center (2015), Child Neurology
University of Texas Medical Branch - Galveston (2012), Pediatrics
Children's Mercy Hospital (2020), Pediatric Epilepsy
Board Certification
American Board of Psy&Neurology/Child Neurology,
American Board of Psychiatry And Neurology(Epilepsy)


Departments and Programs

  • Research Interests

    • Genetic Epileptic Encephalopathies
    • Medically Intractable Epilepsy
    • Neonatal Seizures
    • Post-Stroke Epilepsy
  • Publications

    • Time from convulsive status epilepticus onset to anticonvulsant administration in children. Sánchez Fernández I, Abend NS, Agadi S, An S, Arya R, Brenton JN, Carpenter JL, Chapman KE, Gaillard WD, Glauser TA, Goodkin HP, Kapur K, Mikati MA, Peariso K, Ream M, Riviello J, Tasker RC, Loddenkemper T Neurology 2015 Jun 84 23 2304-11
    • Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition. Petrovski S, Shashi V, Petrou S, Schoch K, McSweeney KM, Dhindsa RS, Krueger B, Crimian R, Case LE, Khalid R, El-Dairi MA, Jiang YH, Mikati MA, Goldstein DB, Cold Spring Harbor molecular case studies 2015 Oct 1 1 a000257
    • Sustained therapeutic response to riboflavin in a child with a progressive neurological condition, diagnosed by whole-exome sequencing. Shashi V, Petrovski S, Schoch K, Crimian R, Case LE, Khalid R, El-Dairi MA, Jiang YH, Mikati MA, Goldstein DB, Cold Spring Harbor molecular case studies 2015 Oct 1 1 a000265
  • Professional Activities

    • American Academy of Neurology
    • American Epilepsy Society
    • International Pediatric Stroke Organization
    • Newborn Brain Society
  • Awards and Honors

    • Rockstar Hall of Fame for highest patient satisfaction scores 2021, Children’s Mercy Kansas City
    • Travel Scholarship 2020, American Clinical Neurophysiology Meeting
    • Fellows Program 2019, American Epilepsy Society Annual Meeting
    • Neurology Program Development Award 2019, Children’s Mercy Kansas City
    • Best Clinical Team Faculty Award for Stroke Team 2019, Department of Pediatrics, Children’s Mercy Kansas City
    • Clinical Excellence Faculty Award 2018, Department of Neurology, Children’s Mercy Kansas City
    • University of Texas Medical Branch Resident Representative 2011-2012, Texas Pediatric Society

Where I Provide Care: